The Chefs’ Warehouse, Inc. to Present at the 19th Annual ICR Conference
Dec 29, 2016 13:30 pm UTC| Business
RIDGEFIELD, Conn., Dec. 29, 2016 -- The Chefs’ Warehouse, Inc. (NASDAQ:CHEF), a premier distributor of specialty food products in the United States, today announced that Christopher Pappas, chairman, president and chief...
Cuba Ventures Announces Tim Fernback as CFO and Re-Election of Directors at the AGM
Dec 29, 2016 13:30 pm UTC| Business
VANCOUVER, British Columbia, Dec. 29, 2016 -- Cuba Ventures Corp. (TSX-V:CUV) (OTCBB:MPSFF) (the “Company”) is pleased to announce that the Company has appointed Tim Fernback MBA, CPA, CMA as its Chief Financial Officer...
Skyline Medical Receives Requested Extension from Nasdaq Panel
Dec 29, 2016 13:30 pm UTC| Business
MINNEAPOLIS, Dec. 29, 2016 -- Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, announces the Nasdaq...
Dec 29, 2016 13:30 pm UTC| Business
DANBURY, Conn., Dec. 29, 2016 -- FuelCell Energy, Inc. (Nasdaq:FCEL), a global leader in the design, manufacture, operation and project development of ultra-clean, efficient and reliable fuel cell power plants, today...
The why and how of successful corporate giving
Dec 29, 2016 13:01 pm UTC| Insights & Views Business
Economic downturns are typically accompanied by a reduction in charitable giving, and corporate giving is sometimes slower to re-materialise than individual giving. But our research of the top 100 ASX Australian Companies...
Intellipharmaceutics to Present at the Biotech Showcase™
Dec 29, 2016 13:00 pm UTC| Business
TORONTO, Dec. 29, 2016 -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of...
Aptose Biosciences Provides Update on APTO-253 Development
Dec 29, 2016 13:00 pm UTC| Business
SAN DIEGO and TORONTO, Dec. 29, 2016 -- Aptose Biosciences Inc. (NASDAQ:APTO) (TSX:APS), a clinical-stage company developing new therapeutics and molecular diagnostics that target the underlying mechanisms of cancer,...